I

n a high-stakes battle between drug makers and insurers, last week it was the drug makers who got a lift, on a little-noticed issue and in an unusual place: Arkansas.

The governor there signed legislation to make Arkansas the 43rd state since 2008 to enact so-called oral parity laws, which prohibit certain private insurers from charging cancer patients more in copays if they take chemo in pill form instead of getting it infused into their veins. Patient groups are pushing similar legislative campaigns in North Carolina, Tennessee, Michigan, and at the federal level.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine